Due to this fact, CMS issued a whole new product code for casirivimab and imdevimab of 600 mg (Q0240) and a pair of new codes for that administration of repeat doses of casirivimab and imdevimab (M0240/M0241). Companies who administer casirivimab and imdevimab for PEP really should use M0243 or M0244 https://jonahw579zcd4.p2blogs.com/profile